NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
NF-κB associated markers of prognosis in early and metastatic triple negative breast cancer ; volume:26 ; number:1 ; day:2 ; month:12 ; year:2024 ; pages:1-19 ; date:12.2024
Breast cancer research ; 26, Heft 1 (2.12.2024), 1-19, 12.2024
- Urheber
-
De La Cruz, Payton
McAdams, Julia
Morales Aquino, Melanie
Fernandez, Aileen I.
Elliott, Andrew
Lustberg, Maryam
Schorl, Christoph
Ribeiro, Jennifer R.
James, Nicole E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-024-01925-3
- URN
-
urn:nbn:de:101:1-2502162122014.977366028809
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- De La Cruz, Payton
- McAdams, Julia
- Morales Aquino, Melanie
- Fernandez, Aileen I.
- Elliott, Andrew
- Lustberg, Maryam
- Schorl, Christoph
- Ribeiro, Jennifer R.
- James, Nicole E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Metastatic Triple-Negative Breast Cancer
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
Clinical features and prognosis of cardiac metastatic tumors
Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer
Metastatic and triple-negative breast cancer: challenges and treatment options
Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis
Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Metastatic Triple-Negative Breast Cancer
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
Clinical features and prognosis of cardiac metastatic tumors
Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer
Metastatic and triple-negative breast cancer: challenges and treatment options
Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis
Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Metastatic Triple-Negative Breast Cancer
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
Clinical features and prognosis of cardiac metastatic tumors
Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer
Metastatic and triple-negative breast cancer: challenges and treatment options
Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis